Pure Global
NCT06141148

Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate

Clinical Presentaion, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate
Sohag University·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Tuberculosis
Drug/Device/Intervention
sputum analysis
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sohag University
Location
Sohag, Egypt
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Dec 30, 2024
Enrollment
200 participants
Primary outcome

percent of cured tuberculous patients,percent of treatment failure

Summary

Tuberculosis (TB) is an infectious disease that commonly affects the lung and is caused by a
 bacterium called Mycobacterium Tuberculosis. The bacterium mostly affects people with
 impaired immunity TB becomes the second leading cause of morbidity and mortality among
 infectious diseases, following the emergence of the human immunodeficiency virus (HIV). HIV
 is the commonest risk factor for developing a life-threatening tuberculosis disease, on the
 other hand, HIV related immunodeficiency is worsened by TB infection.TB is among the top 10
 causes of death worldwide. In2019, among 8.8 million adults who developed TB disease, 36%
 were women .TB has become the fifth leading cause of death among women.

ICD-10 classifications
TuberculosisLatent tuberculosisTuberculosis of other organsCongenital tuberculosisSequelae of tuberculosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06141148
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06141148 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Recruiting. The study focuses on Tuberculosis. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.